Thiazolopyrimidines for use in therapy

US8349845B2 · kind B2 · utility

Assignee

• Sosei Group Corporation · JP

Inventors

• Fei-Yue Zhao · Coventry, GB
• Alistair Dixon · London, GB
• Jonathan Mark Treherne · Coventry, GB
• Chizuko Koseki · London, GB
• Kevin J. Lee · Beaverton, US
• David Spanswick · Coventry, GB

Key dates

• Filing date: Jun 19, 2006
• Grant date: Jan 8, 2013
• Expiry date: Jan 14, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P29/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Use of a compound of formula (I) wherein R is an alicyclic group; an arylethyl group; or phenyl or benzyl substituted by halogen, lower alkyl, alkoxy, OH, NH2, NHalkyl, N(alkyl)2, CN or NO2; in the manufacture of a medicament for the therapy of hyperalgesic pain conditions and their symptoms.